PCT Guided Antibiotics Use in Critically Ill Adult Patients in China
Condition(s) studied
Investigational drug(s) / intervention(s)
PCT detection: Clinicians will prescribe PCT tests every day for enrolled patients, with assigning a dedicated person monitoring the daily PCT results. Once the PCT \<0.5 ng/ml or ΔPCT (drop from the peak value) \>80%, the clinicians will receive a notification and will strictly adhere to guidelines and PCT values to adjust antibiotic prescriptions.
Study summary
Procalcitonin (PCT) has been widely used in the diagnosis and treatment of bacterial infectious diseases in China. The investigators aim to establish an algorithm based on BRAHMS PCT (VIDAS PCT) for patients with severe infections or sepsis in the EICU to reduce antibiotic exposure and verify its validity in the reduction of antibiotic exposure, clinical outcomes and costs saving.
Eligibility
Primary outcome measure(s)
- Total duration of antibiotics use — From the day the patient was admitted to the EICU until the patient left the EICU, calculate how many days were antibiotics used.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| China-Japan Friendship Hospital | Beijing | China |
More China-Japan Friendship Hospital trials in Japan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06945510 on ClinicalTrials.gov ↗ ← All trials in Japan